Literature DB >> 16126174

Six lysine residues on c-Myc are direct substrates for acetylation by p300.

Kangling Zhang1, Francesco Faiola, Ernest Martinez.   

Abstract

The c-Myc oncoprotein (Myc) functions as a transcription regulator in association with an obligatory partner, Max, to control cell growth and differentiation. The Myc:Max complex regulates specific genes by recognizing "E-box" DNA sequences and promoter-bound factors such as Miz-1. Myc recruits histone acetyltransferases (HATs) to modify chromatin and is, itself, acetylated in mammalian cells by several of these HATs including p300/CBP, GCN5, and Tip60. The Myc residues that are directly modified by these different HATs remain unknown. Here, we have analyzed the acetylation of recombinant Myc:Max complexes by purified p300 HAT in vitro by using MALDI-TOF and LC-ESI-MS/MS mass spectrometry. These analyses identify six lysine residues in human Myc (K143, K157, K275, K317, K323, and K371) as direct substrates for p300. Our results further indicate that p300 can acetylate DNA-bound Myc:Max complexes and that acetylated Myc:Max heterodimers efficiently interact with Miz-1.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16126174     DOI: 10.1016/j.bbrc.2005.08.075

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  26 in total

1.  Acetylation of Nrf2 by p300/CBP augments promoter-specific DNA binding of Nrf2 during the antioxidant response.

Authors:  Zheng Sun; Y Eugene Chin; Donna D Zhang
Journal:  Mol Cell Biol       Date:  2009-03-09       Impact factor: 4.272

Review 2.  Small-molecule inhibitors of the Myc oncoprotein.

Authors:  Steven Fletcher; Edward V Prochownik
Journal:  Biochim Biophys Acta       Date:  2014-03-19

3.  Acetylation of the c-MYC oncoprotein is required for cooperation with the HTLV-1 p30(II) accessory protein and the induction of oncogenic cellular transformation by p30(II)/c-MYC.

Authors:  Megan M Romeo; Bookyung Ko; Janice Kim; Rebecca Brady; Hayley C Heatley; Jeffrey He; Carolyn K Harrod; Braden Barnett; Lee Ratner; Michael D Lairmore; Ernest Martinez; Bernhard Lüscher; Craig N Robson; Marie Henriksson; Robert Harrod
Journal:  Virology       Date:  2015-01-05       Impact factor: 3.616

4.  Max is acetylated by p300 at several nuclear localization residues.

Authors:  Francesco Faiola; Yi-Ting Wu; Songqin Pan; Kangling Zhang; Anthony Farina; Ernest Martinez
Journal:  Biochem J       Date:  2007-05-01       Impact factor: 3.857

5.  PIAS1 Promotes Lymphomagenesis through MYC Upregulation.

Authors:  Andrea Rabellino; Margherita Melegari; Van S Tompkins; Weina Chen; Brian G Van Ness; Julie Teruya-Feldstein; Maralice Conacci-Sorrell; Siegfried Janz; Pier Paolo Scaglioni
Journal:  Cell Rep       Date:  2016-05-26       Impact factor: 9.423

6.  Reduced chromatin binding of MYC is a key effect of HDAC inhibition in MYC amplified medulloblastoma.

Authors:  Jonas Ecker; Venu Thatikonda; Gianluca Sigismondo; Florian Selt; Gintvile Valinciute; Ina Oehme; Carina Müller; Juliane L Buhl; Johannes Ridinger; Diren Usta; Nan Qin; Cornelis M van Tilburg; Christel Herold-Mende; Marc Remke; Felix Sahm; Frank Westermann; Marcel Kool; Robert J Wechsler-Reya; Lukas Chavez; Jeroen Krijgsveld; Natalie Jäger; Stefan M Pfister; Olaf Witt; Till Milde
Journal:  Neuro Oncol       Date:  2021-02-25       Impact factor: 12.300

7.  Dual regulation of c-Myc by p300 via acetylation-dependent control of Myc protein turnover and coactivation of Myc-induced transcription.

Authors:  Francesco Faiola; Xiaohui Liu; Szuying Lo; Songqin Pan; Kangling Zhang; Elena Lymar; Anthony Farina; Ernest Martinez
Journal:  Mol Cell Biol       Date:  2005-12       Impact factor: 4.272

8.  Trichostatin A enhances acetylation as well as protein stability of ERalpha through induction of p300 protein.

Authors:  Sung-Hye Kim; Hyun-Jin Kang; Hyelin Na; Mi-Ock Lee
Journal:  Breast Cancer Res       Date:  2010-04-13       Impact factor: 6.466

9.  Dual regulation of Myc by Abl.

Authors:  V J Sanchez-Arévalo Lobo; M Doni; A Verrecchia; S Sanulli; G Fagà; A Piontini; M Bianchi; M Conacci-Sorrell; G Mazzarol; V Peg; J H Losa; P Ronchi; M Ponzoni; R N Eisenman; C Doglioni; B Amati
Journal:  Oncogene       Date:  2013-01-14       Impact factor: 9.867

10.  MYCN concurrence with SAHA-induced cell death in human neuroblastoma cells.

Authors:  Constanza Cortés; Sara C Kozma; Albert Tauler; Santiago Ambrosio
Journal:  Cell Oncol (Dordr)       Date:  2015-08-26       Impact factor: 6.730

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.